Get Quote

Keryx Biopharmaceuticals (NASDAQ:KERX)

CAPS Game Rating: 2 out of 5

A biopharmaceutical company focused on the acquisition, development and commercialization of medically important, novel pharmaceutical products for the treatment of life-threatening diseases, including diabetes and cancer.

For details about CAPS-UK, and the conditions you agree to be bound by, please see our Terms and Conditions.